121 related articles for article (PubMed ID: 32568409)
21. T-cell homeostasis in chronic HCV-infected patients treated with interferon and ribavirin or an interferon-free regimen.
Hartling HJ; Birch C; Gaardbo JC; Hove M; Trøseid M; Clausen MR; Gerstoft J; Ullum H; Nielsen SD
APMIS; 2015 Oct; 123(10):903-11. PubMed ID: 26279289
[TBL] [Abstract][Full Text] [Related]
22. T helper type 1/T helper type 17-related cytokines in chronic hepatitis C patients before and after interferon and ribavirin therapy.
Fathy A; Ahmed AS; Metwally L; Hassan A
Med Princ Pract; 2011; 20(4):345-9. PubMed ID: 21576995
[TBL] [Abstract][Full Text] [Related]
23. Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy).
Halfon P; Pérusat S; Bourlière M; Bronowicki JP; Trimoulet P; Benhamou Y; Leroy V; Marcellin P; Foucher J; Penaranda G; Chêne G; Couzigou P;
J Med Virol; 2010 Dec; 82(12):2027-31. PubMed ID: 20981789
[TBL] [Abstract][Full Text] [Related]
24. Dual role of IL-12 in the therapeutic efficacy or failure during combined PEG-Interferon-α2A and ribavirin therapy in patients with chronic hepatitis C.
Araújo AR; Peruhype-Magalhães V; Coelho-dos-Reis JG; Chaves LP; de Lima TA; Pimentel JP; de Paula L; de Almeida CM; Tarragô AM; Tateno A; Levi JE; Teixeira-Carvalho A; Martins-Filho OA; Lira Eda F; Torres KL; Talhari S; Malheiro A
Immunol Lett; 2013; 154(1-2):61-9. PubMed ID: 23973662
[TBL] [Abstract][Full Text] [Related]
25. Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI).
Couzigou P; Pérusat S; Bourlière M; Trimoulet P; Poynard T; Leroy V; Marcellin P; Foucher J; Bronowicki JP; Chêne G;
J Gastroenterol Hepatol; 2013 Feb; 28(2):329-34. PubMed ID: 23190183
[TBL] [Abstract][Full Text] [Related]
26. Negative regulation of hepatitis C virus specific immunity is highly heterogeneous and modulated by pegylated interferon-alpha/ribavirin therapy.
Claassen MA; de Knegt RJ; Turgut D; Groothuismink ZM; Janssen HL; Boonstra A
PLoS One; 2012; 7(11):e49389. PubMed ID: 23145169
[TBL] [Abstract][Full Text] [Related]
27. Pegylated interferon α enhances recovery of memory T cells in e antigen positive chronic hepatitis B patients.
Liu YZ; Hou FQ; Ding P; Ren YY; Li SH; Wang GQ
Virol J; 2012 Nov; 9():274. PubMed ID: 23158844
[TBL] [Abstract][Full Text] [Related]
28. Monocyte-derived dendritic cells in children with chronic hepatitis C: correlation with interferon and ribavirin therapy.
Khedr MA; E Behairy B; Hussein ME; Marei AM; Nage SA; Zakaria HM
Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1170-4. PubMed ID: 26148246
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.
Chen LW; Chien RN; Yen CL; Chang JJ; Liu CJ; Lin CL
J Gastroenterol Hepatol; 2010 Feb; 25(2):259-63. PubMed ID: 19817959
[TBL] [Abstract][Full Text] [Related]
30. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India.
Chandele A; Sewatanon J; Gunisetty S; Singla M; Onlamoon N; Akondy RS; Kissick HT; Nayak K; Reddy ES; Kalam H; Kumar D; Verma A; Panda H; Wang S; Angkasekwinai N; Pattanapanyasat K; Chokephaibulkit K; Medigeshi GR; Lodha R; Kabra S; Ahmed R; Murali-Krishna K
J Virol; 2016 Dec; 90(24):11259-11278. PubMed ID: 27707928
[TBL] [Abstract][Full Text] [Related]
31. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.
Wedemeyer H; He XS; Nascimbeni M; Davis AR; Greenberg HB; Hoofnagle JH; Liang TJ; Alter H; Rehermann B
J Immunol; 2002 Sep; 169(6):3447-58. PubMed ID: 12218168
[TBL] [Abstract][Full Text] [Related]
32. Peripheral lymphocyte subsets in chronic hepatitis C: Effects of 12 weeks of antiviral treatment with interferon-alpha plus ribavirin.
Oliveira IS; Carvalho LP; Schinoni MI; Paraná R; Atta AM; Atta ML
Microb Pathog; 2016 Feb; 91():155-60. PubMed ID: 26718098
[TBL] [Abstract][Full Text] [Related]
33. Primary defect in CD8+ lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon-gamma (IFN-gamma) in CD28+ ('cytotoxic') and CD28- ('suppressor') CD8+ subsets.
North ME; Webster AD; Farrant J
Clin Exp Immunol; 1998 Jan; 111(1):70-5. PubMed ID: 9472663
[TBL] [Abstract][Full Text] [Related]
34. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.
Nakamoto N; Kaplan DE; Coleclough J; Li Y; Valiga ME; Kaminski M; Shaked A; Olthoff K; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM
Gastroenterology; 2008 Jun; 134(7):1927-37, 1937.e1-2. PubMed ID: 18549878
[TBL] [Abstract][Full Text] [Related]
35. In vivo interferon-alpha/ribavirin treatment modulates Vγ9Vδ2 T-cell function during chronic HCV infection.
Cimini E; Bonnafous C; Sicard H; Vlassi C; D'Offizi G; Capobianchi MR; Martini F; Agrati C
J Interferon Cytokine Res; 2013 Mar; 33(3):136-41. PubMed ID: 23308376
[TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up after successful interferon therapy of acute hepatitis C.
Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus-specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells.
Roque-Cuéllar MC; Sánchez B; García-Lozano JR; Praena-Fernández JM; Márquez-Galán JL; Núñez-Roldán A; Aguilar-Reina J
Liver Int; 2014 Jul; 34(6):e80-8. PubMed ID: 24127783
[TBL] [Abstract][Full Text] [Related]
38. Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy.
Myers RP; Benhamou Y; Bochet M; Thibault V; Mehri D; Poynard T
AIDS; 2004 Jan; 18(1):75-9. PubMed ID: 15090832
[TBL] [Abstract][Full Text] [Related]
39. Early decrease of interferon-gamma+ and interleukin-2+ T cells during combination treatment with interferon-alpha and ribavirin in patients with chronic hepatitis C.
Krampera M; Fattovich G; Scupoli MT; Pizzolo G
Am J Gastroenterol; 2000 Dec; 95(12):3670-3. PubMed ID: 11151933
[No Abstract] [Full Text] [Related]
40. [Dynamic changes in programmed death-1 expression on the surface of T cells in chronic hepatitis C patients undergoing interferon therapy].
Dong RQ; Zhou DF; Han R; Zhou JY; Zhao CY; Zhen Z
Zhonghua Gan Zang Bing Za Zhi; 2013 Dec; 21(12):899-902. PubMed ID: 24636290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
